Kedudukan dalam Saham
#39776
Hexima Limited is a biotechnology firm focused on the discovery and advancement... Hexima Limited is a biotechnology firm focused on the discovery and advancement of plant-derived proteins and peptides for medical applications in humans. Its primary drug candidate, pezadeftide, a plant defensin, is presently undergoing Phase IIb clinical evaluations in Australia and New Zealand to address fungal toenail infections. The company was established in 1997 and its main operations are situated in Preston, Australia.
Harga Saham
$0.0084929
Disegerakkan terakhir: 2024-11-12
Perubahan (1 hari)
-0.64%
Perubahan (1 tahun)
0.00%
Perdagangan Hexima Limited (HXL)
Harga HXL dengan permodalan pasaran b
Modal pasaran bagi Hexima Limited(HXL)
Modal Pasaran: $354.66K
Sehingga August 2026, Hexima Limited mempunyai modal pasaran sebanyak $354.66K. Ini menjadikan Hexima Limited syarikat ke-39776th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Hexima Limited dari 2007 hingga 2026
HXL berbanding dengan 5 teratas yang paling popular stocks
| Harga HXL |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.470T
|
+1,542,179,604.34%
|
|
|
|
|
$4.467T
|
+1,259,526,175.73%
|
|
|
|
|
$4.174T
|
+1,177,001,356.73%
|
|
|
|
|
$3.700T
|
+1,043,266,143.47%
|
|
|
|
|
$2.854T
|
+804,804,539.63%
|
